Classroom Exercise Snacks for Creativity, Motor Skills, and Academic Engagement in Elementary School Children
NCT07899242, Not applicable, Completed, Islamic Azad University, Abadan Branch
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Classroom Exercise Snacks for Creativity, Motor Skills, and Academic Engagement in Elementary School Children | ClinicalTrials.gov |
| NCT number | NCT07899242 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 242 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Islamic Azad University, Abadan Branch | ClinicalTrials.gov |
| Conditions | Child Development, Motor Skills, Executive Function | ClinicalTrials.gov |
| Interventions | Classroom-Based Exercise Snacks | ClinicalTrials.gov |
| First posted | 2026-10-27 | ClinicalTrials.gov |
| Last updated | 2026-10-29 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Motor Competence | Baseline (pre-intervention) and post-intervention (after 20 weeks). | Motor competence was assessed using the short form of the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2). The BOT-2 Short Form yields a Total Motor Composite standard score. The minimum possible score is 20 and the maximum possible score is 80 (standard score scale). Higher scores indicate better motor competence. The total composite score was used as the primary indicator of motor competence. | ClinicalTrials.gov |
| Primary | Creativity | Baseline (pre-intervention) and post-intervention (after 20 weeks). | Creativity was assessed using the Torrance Tests of Creative Thinking (TTCT) - Figural Form. The test evaluates divergent thinking and creative potential through standardized figural tasks. The Total Creativity Index (a standard score) was used for analysis. The minimum possible score on the standard score scale is 20 and the maximum is 160 (with a mean of 100 and standard deviation of 20). Higher scores indicate better creative potential (i.e., greater divergent thinking ability). | ClinicalTrials.gov |
| Secondary | Physical Fitness Composite Score | Baseline (pre-intervention) and post-intervention (after 20 weeks). | Overall physical fitness was assessed using a composite score derived from three tests of the EUROFIT battery: the 10×5 m shuttle run, standing long jump, and sit-up test. Raw scores from each test were standardized using z-score transformation and then averaged to create a single composite score. The composite score is a standardized z-score (sample mean = 0, standard deviation = 1); it does not have fixed minimum or maximum values, as the theoretical range is unbounded. Higher (more positive) scores indicate better overall physical fitness, while lower (more negative) scores indicate poorer physical fitness. | ClinicalTrials.gov |
| Secondary | Executive Function Composite Score | Baseline (pre-intervention) and post-intervention (after 20 weeks). | Executive function was assessed using a battery of neuropsychological tasks: the Stroop Test, Trail Making Test-Part B (TMT-B), and Digit Span Test. A composite score was calculated by standardizing and averaging the scores from these measures. The resulting composite is a standardized z-score (sample mean = 0, standard deviation = 1); it does not have fixed minimum or maximum values, as the theoretical range is unbounded. Higher (more positive) composite scores indicate better executive function, while lower (more negative) scores indicate poorer executive function. | ClinicalTrials.gov |
| Secondary | Academic Engagement | Baseline (pre-intervention) and post-intervention (after 20 weeks). | Academic engagement was assessed using the Fredricks Academic Engagement Questionnaire. The minimum possible total score is 19 and the maximum possible total score is 95. Higher scores indicate greater academic engagement, while lower scores reflect poorer engagement. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)